abstract |
The present disclosure relates generally to antiviral compounds, and more specifically, combinations of compounds capable of inhibiting the function of NS5A protein encoded by hepatitis C virus (HCV), compositions comprising such combinations, and functions of NS5A protein Relates to a method for inhibiting. |